annual EBIT:
-$239.65M-$69.43M(-40.79%)Summary
- As of today (July 11, 2025), RYTM annual earnings before interest & taxes is -$239.65 million, with the most recent change of -$69.43 million (-40.79%) on December 31, 2024.
- During the last 3 years, RYTM annual EBIT has fallen by -$170.04 million (-244.27%).
- RYTM annual EBIT is now -2166.65% below its all-time high of -$10.57 million, reached on December 31, 2015.
Performance
RYTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$44.01M-$6.07M(-16.01%)Summary
- As of today (July 11, 2025), RYTM quarterly earnings before interest & taxes is -$44.01 million, with the most recent change of -$6.07 million (-16.01%) on March 31, 2025.
- Over the past year, RYTM quarterly EBIT has increased by +$92.31 million (+67.72%).
- RYTM quarterly EBIT is now -588.82% below its all-time high of -$6.39 million, reached on March 31, 2017.
Performance
RYTM quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$147.87M+$92.31M(+38.43%)Summary
- As of today (July 11, 2025), RYTM TTM earnings before interest & taxes is -$147.87 million, with the most recent change of +$92.31 million (+38.43%) on March 31, 2025.
- Over the past year, RYTM TTM EBIT has increased by +$109.38 million (+42.52%).
- RYTM TTM EBIT is now -2210.05% below its all-time high of -$6.40 million, reached on September 30, 2016.
Performance
RYTM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
RYTM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -40.8% | +67.7% | +42.5% |
| 3 y3 years | -244.3% | +16.6% | +21.4% |
| 5 y5 years | -64.2% | -24.7% | -6.7% |
RYTM EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -244.3% | at low | -61.9% | +67.7% | at high | +42.5% |
| 5 y | 5-year | -244.3% | at low | -61.9% | +67.7% | -11.1% | +42.5% |
| alltime | all time | -2166.7% | at low | -588.8% | +67.7% | -2210.1% | +42.5% |
RYTM EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$44.01M(+16.0%) | -$147.87M(-38.4%) |
| Dec 2024 | -$239.65M(+40.8%) | -$37.94M(-2.1%) | -$240.17M(+0.4%) |
| Sep 2024 | - | -$38.74M(+42.5%) | -$239.13M(-0.8%) |
| Jun 2024 | - | -$27.18M(-80.1%) | -$241.03M(-6.3%) |
| Mar 2024 | - | -$136.32M(+269.6%) | -$257.25M(+51.3%) |
| Dec 2023 | -$170.22M(-3.2%) | -$36.89M(-9.2%) | -$170.05M(-1.5%) |
| Sep 2023 | - | -$40.65M(-6.3%) | -$172.65M(+1.1%) |
| Jun 2023 | - | -$43.40M(-11.6%) | -$170.72M(-0.9%) |
| Mar 2023 | - | -$49.12M(+24.4%) | -$172.27M(-2.1%) |
| Dec 2022 | -$175.92M(+152.7%) | -$39.48M(+2.0%) | -$175.92M(-6.1%) |
| Sep 2022 | - | -$38.72M(-13.9%) | -$187.29M(-2.8%) |
| Jun 2022 | - | -$44.95M(-14.8%) | -$192.68M(+2.4%) |
| Mar 2022 | - | -$52.76M(+3.8%) | -$188.15M(+10.8%) |
| Dec 2021 | -$69.61M(-48.0%) | -$50.85M(+15.3%) | -$169.79M(+12.1%) |
| Sep 2021 | - | -$44.10M(+9.1%) | -$151.43M(+6.9%) |
| Jun 2021 | - | -$40.43M(+17.5%) | -$141.61M(+6.4%) |
| Mar 2021 | - | -$34.40M(+5.9%) | -$133.09M(-0.7%) |
| Dec 2020 | -$134.00M | -$32.49M(-5.2%) | -$134.00M(-1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$34.28M(+7.4%) | -$135.73M(-2.0%) |
| Jun 2020 | - | -$31.92M(-9.6%) | -$138.55M(-8.1%) |
| Mar 2020 | - | -$35.30M(+3.1%) | -$150.78M(+3.3%) |
| Dec 2019 | -$146.00M(+86.2%) | -$34.22M(-7.8%) | -$146.00M(+5.1%) |
| Sep 2019 | - | -$37.11M(-16.0%) | -$138.93M(+14.8%) |
| Jun 2019 | - | -$44.15M(+44.7%) | -$121.06M(+31.7%) |
| Mar 2019 | - | -$30.52M(+12.4%) | -$91.94M(+17.2%) |
| Dec 2018 | -$78.42M(+141.9%) | -$27.15M(+41.1%) | -$78.42M(+26.0%) |
| Sep 2018 | - | -$19.24M(+28.1%) | -$62.25M(+21.4%) |
| Jun 2018 | - | -$15.02M(-11.6%) | -$51.29M(+19.2%) |
| Mar 2018 | - | -$17.00M(+54.8%) | -$43.02M(+32.7%) |
| Dec 2017 | -$32.41M(+25.1%) | -$10.98M(+32.5%) | -$32.41M(+8.8%) |
| Sep 2017 | - | -$8.29M(+22.7%) | -$29.80M(+6.8%) |
| Jun 2017 | - | -$6.75M(+5.7%) | -$27.92M(+31.9%) |
| Mar 2017 | - | -$6.39M(-23.7%) | -$21.16M(+43.2%) |
| Dec 2016 | -$25.91M(+145.0%) | -$8.38M(+30.8%) | -$14.78M(+130.8%) |
| Sep 2016 | - | -$6.40M | -$6.40M |
| Dec 2015 | -$10.57M | - | - |
FAQ
- What is Rhythm Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Rhythm Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Rhythm Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Rhythm Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of RYTM is -$239.65M
What is the all time high annual EBIT for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is -$10.57M
What is Rhythm Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, RYTM annual earnings before interest & taxes has changed by -$69.43M (-40.79%)
What is Rhythm Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of RYTM is -$44.01M
What is the all time high quarterly EBIT for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is -$6.39M
What is Rhythm Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, RYTM quarterly earnings before interest & taxes has changed by +$92.31M (+67.72%)
What is Rhythm Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of RYTM is -$147.87M
What is the all time high TTM EBIT for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is -$6.40M
What is Rhythm Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, RYTM TTM earnings before interest & taxes has changed by +$109.38M (+42.52%)